The invention relates to a method and an apparatus to identify alveolar opening and collapse of a lung. To automatically generate the settings of ventilator parameters in a simple and gentle way, the hemoglobin oxygen saturation and/or the endtidal CO2 concentration and/or the CO2 output are-measured and processing to detect alveolar opening and closing. From the knowledge of the corresponding airway pressures, a central processing unit may generate the settings of ventilation parameters such that gas exchange is maximal while the mechanical stress of the lung tissue is minimal.
|
10. Method for determining the alveolar opening or closing of a lung ventilated by an artificial ventilator, comprising the steps of:
measuring the CO2 output (CO2 volume exhaled per unit time), and
changing the airway pressure (paw), wherein from the observation of the resulting course of the measured CO2 output the airway pressure level at which alveolar opening or closing occurs is determined.
1. Method for determining the alveolar opening or closing of a lung ventilated by an artificial ventilator, comprising the steps of:
measuring the hemoglobin oxygen saturation (SO2), and
changing the airway pressure (Paw) wherein from the observation of the resulting course of the measured hemoglobin oxygen saturation (SO2) the airway pressure level at which alveolar opening or closing occurs is determined.
17. Apparatus for determining the alveolar opening or closing of a lung, comprising:
an artificial ventilator for ventilating a lung,
a sensor to measure CO2 output (CO2 volume exhaled per unit time), and
a data processor which determines during a change of the airway pressure (paw) from the resulting course of the measured CO2 output the airway pressure level at which alveolar opening or closing occurs.
16. Apparatus for determining the alveolar opening or closing of a lung, comprising:
an artificial ventilator for ventilating a lung,
a sensor to measure endtidal CO2 concentration (etCO2), and
a data processor which determines during a change of the airway pressure (paw) from the resulting course of the measured endtidal CO2 concentration the airway pressure level at which alveolar opening or closing occurs.
6. Method for determining the alveolar opening or closing of a lung ventilated by an artificial ventilator, comprising the steps of:
measuring the endtidal CO2 concentration in the expired gas (etCO2), and
changing the airway pressure (paw), wherein from the observation of the resulting course of the measured endtidal CO2 concentration the airway pressure level at which alveolar opening or closing occurs is determined.
14. Apparatus for determining the alveolar opening or closing of a lung, comprising:
an artificial ventilator for ventilating a lung,
a saturation sensor for measuring the hemoglobin oxygen saturation (SO2), and
a data processor which determines during a change of the airway pressure (paw) from the resulting course of the measured hemoglobin oxygen saturation (SO2) the airway pressure level at which alveolar opening or closing occurs.
2. Method according to
3. Method according to
4. Method according to
5. Method according to
7. Method according to
8. Method according to
9. Method according to
11. Method according to
12. Method according to
13. Method according to
15. Apparatus according to
|
This application is a Continuation of prior application No. PCT/EP00/00685, filed on Jan. 28, 2000.
The present invention relates to a method and an apparatus to determine the alveolar opening and/or closing of a lung.
Such a method and such an apparatus are especially useful to optimally set the control variables of an artificial ventilator as both the alveolar opening and the alveolar closing are important parameters of an atelectatic (=partially collapsed) lung.
In German intensive care units (ICUs), approximately 8.000-10.000 are artificially ventilated each day. The ventilator control variables, such as airway pressure (Paw) and respiratory rate (RR), are usually chosen based on known standard procedures, but often left constant afterwards and not adapted to the changing needs of a specific patient.
Today, the success of artificial ventilation is evaluated by using arterial blood gas analysis during which the partial pressures of oxygen (paO2) and carbon dioxide (paCO2) are determined. However, quite often these values are measured only 1-4 times a day. Since a human performs about 20.000 breath strokes per day, it becomes obvious that such a low “sampling rate” may not be sufficient to evaluate the status in critical and unstable patients.
Patients with an acute respiratory distress syndrome (ARDS) usually belong to this group of critical patients. Despite all sucesses in intensive care medicine, ARDS still is a pathological state with a mortality of 50%. The basic patho-physiological mechanism is the lack of “surfactant”, a substance which reduces suface tension resulting in a collapse of major lung fractions and a dramatically reduced gas exchange area.
To prevent undesirable sequelae and consecutive multiorgan failure, one important goal of protective ventilator therapy should be a gentle and early “reopening” of the lung. Choosing the airway pressures properly has an important impact on this.
Through the identification of the alveolar opening and especially of the alveolar closing pressures, a distressed lung may be kept open by proper choice of the airway pressure. However, the manual determination of opening and closing pressures is arduous and time consuming. To use the present invention in clinical practice, an automatic, computerized strategy is strongly recommended.
Prior to citing known methods to identify a lung collapse, a basic introduction to artificial ventilation shall be given:
The major function of the lung is the gas exchange, i.e. providing sufficient O2 to the circulation and eliminating CO2 from the body. If a human is not capable to perform this gas exchange himself anymore, he must be ventilated artificially.
During spontaneous ventilation, contraction of the diaphragm produces a subathmospheric pressure within the lung which causes air to be sucked into the lung. By contrst, in most modern forms of artificial ventilation a positive airway pressure is applied to the patient which presses air into the lung (“excess pressure ventilation”).
There are two major forms of ventilatory support: assisted (=augmented) and mandatory (=controlled) artificial ventilation.
In augmented artificial ventilation, the activity of the patient is monitored, either by detecting inspiratory flows sufficient to trigger an artificial breath stroke or by allowing the patient to breathe on top of a basic mandatory ventilatory support. These ventilation modes are especially used during weaning from the ventilator. By contrast, controlled mechanical ventilation (i.e. artificial ventilation without spontaneous breathing activity) is usually applied to more severly ill patients in which complete control of the breathing is desirable or necessary.
There are two major forms of controlled mechanical ventilation, namely pressure- and volume-controlled ventilation.
During pressure-controlled ventilation, the airway pressure is kept at desired levels during inspiration as well as during expiration. The corresponding pressure levels may be named, “peak inspiratory pressure” (PIP) and “positive end-expiratory pressure” (PEEP). Note that the alveolar pressure Palv actually varies in between these two pressure levels.
On the ventilator, several control variables must be adjusted according to the patient needs including the respiratory rate (RR) and the inspiration to expiration ratio (I/E). The following eqn. describe the relationships
with Tinsp the inspiration and Texp the expiration time. The inspired and exhaled volume during quiet breathing is named tidal volume (VT). Assuming a stationary operation and no leakage in the breathing system, VT is given by
During volume-controlled ventilation, a konstant air flow is applied during inspiration while expiration occurs passively against a given PEEP.
Note that volume-controlled ventilation guarantees delivery of a certain tidal volume while pressure-controlled ventilation does not. For this reason, some clinicians still prefer this form of mandatory ventilation. However, depending on the actual lung condition there are major disadvantages. In patients with a stiff lung, for example, Palv may reach undesirable limits and cause barotrauma. Furthermore, due to lung inhomogenities, local lung air flows may arise (so called “Pendelluft”).
From Leonhardt, S., Böhm, S. and Lachmann, B. “Optimierung der Beatmung beim akuten Lungenversagen durch Identifikation physiologischer Kenngroessen”, Automatisierungstechnik (at), Vol. 46, No. 11, pp 532-539, 1998 as well as from U.S. Pat. Nos. 5,660,170, 5,738,090 and 5,752,509, it is known that the airway pressures required to open or close a specific lung can generally be identified from measurements of the arterial oxygen partial pressure (paO2). After the identification procedure, the authors suggest to ventilate above the closing pressure.
It is known that both the identification and the later selection of ventilator parameters for long-term ventilation can be accomplished automatically by using a computer. A major disadvantage of this known method is that the measurement of this physiological parameter requires expensive and very sensible catheter systems and introduce possible damage to the patient (infections, bleeding, etc.).
Object of the present invention is to automatically provide a setting of ventilator parameters in critical patients.
This object is solved by a method according to the claims 1, 5 and 6 as well as an apparatus according to the claims 9, 11 and 12. By using the new feedback signals as claimed in this invention, in claim 13 an apparatus is presented aiming at automatic protective artificial ventilation of human lungs.
The invention is based on the cognition that the hemoglobin oxygen saturation (SO2), the endtidal CO2 concentration (etCO2) and the CO2 output (the elimination of CO2 volume from the body per unit time) can easily be obtained noninvasively and may be used, either solely or combined as parameters to identify the alveolar opening and closing pressure levels of the lung. An invasive arterial line is not necessary anymore. All three parameters may be measured outside the body and may well be used as feedback signals for automatic artificial ventilation.
Similar to using the arterial oxygen partial pressure (PaO2) as a parameter to identify alveolar opening or closing pressures, SO2 may be used for this task as well. For example, SO2 may be set to e.g. 80% by adjusting the ventilator in a proper way (e.g. adjust the inspiratory oxygen fraction fiO2). An alveolar opening due to a subsequent increase of ventilation pressure may then be detected by a large increase in SO2. Similiarly, an alveolar collapse due to a reduction of ventilation pressure may indeed be detected by a decrease in SO2.
However, using SO2 directly has the disadvantage that the saturation may temporaily reach rather low values which could cause life threatening situations.
Thus, a related object of this invention is to provide a method in which SO2 is feedback controlled to stay around given setpoints by properly adjusting the inspiratory oxygen fraction fiO2 at the ventilator. In fact, if starting from a low level, the airway pressure is increased continuosly, the fiO2 required to keep SO2 constant will decrease while this fiO2 will increase with a reduction of airway pressure.
For an automatic detection of alveolar opening during a continuous increase of airway pressure, one possibilities is to look for the negative maximum of the gradient of fiO2 set by the controller. Similarily, an alveolar closing may be identified by detecting the positive maximum of the gradient of fiO2 set by the controller during a continuous decrease in airway pressure.
Another related object of this invention is to provide a method in which the endtidal CO2 concentration in the exhaled air flow is measured which can be used to detect alveolar opening or closing of the lung.
In addition or instead, the CO2 output from the body may also be measured and used for the same task. Note that the CO2 output ([ml CO2/min]) may be obtained by continuously measuring the CO2 concentration in the expired air as well as the air flow and the respiratory rate.
When the airway pressure is changed during ventilation, the endtidal CO2 concentration and the CO2 output behave similar. Thus, if the airway pressure is increased starting from a low value, the endtidal CO2 concentration and the CO2 output also increase. If the airway pressure is decreased afterwards, the endtidal CO2 concentration and the CO2 output decrease as well.
Within an automatic signal monitoring device, a criterion for alveolar opening can be to e.g. look for a maximal change in the positive gradient of either the endtidal CO2 concentration or the CO2 output when simulataneously increasing the airway pressure continuously starting from a low value. In other words, during a continuous pressure rise alveolar opening occurs when the second time derivative of etCO2 and/or of CO2 output has a maximum while the first derivative is positive.
Similarily, a criterion for alveolar collapse can be e.g. a maximal change in the negative gradient of either the endtidal CO2 concentration or the CO2 output during a continuous decrease in airway pressure. In other words, alveolar closing occurs during a continuous decrease in airway pressure if the second time derivative of etCO2 and/or of CO2 output has a minimum while the first derivative is negative.
In a preferred embodiment of this invention, the methods for identification of alveolar opening or collapse pressures as claimed in this invention may be used to build a device for protective artificial ventilation in which a central processing unit (CPU) uses the identified opening and closing pressures to automatically set at least one ventilation parameter of an artificial ventilator such that a maximal gas exchange can be achieved while simultaneously minimizing mechanical stress on lung tissue.
Further details and advantages will be discussed with reference to the preferred embodiments given in the following figures.
Note that
Note that for a better understanding of a system and for tuning of control systems, it is generally advisible to obtain a process model first. In the case of artificial ventilation, the model should contain the blocks “ventilator”, “lung mechanics” and “gas exchange”.
Especially the subsystems “lung mechanics” and “gas exchange” are very non-linear. Thus, it is important to analyze the large-scale as well as the small-scale characteristics (see FIG. 5).
When analyzing the small-scale behavior, it must be considered that the bronchial tree actually consists of a branching set of tubes which form the “resistance to air flow” (Rair). In healthy lungs, the major fraction of this resistance is located in generations 3 to 6 of the bronchial tree.
The second parameter that describes small-scale lung mechanics is the so called “compliance of the respiratory system” (Crs) which is mainly determined by the elastic properties of the peripheral lung and thorax tissue.
with pmuse(t) the suction pressure caused by contraction of the diaphragm and Vlung, 0 the lung volume at rest. The dynamics of the lung mechanics may be described by the respiratory time constant
Trs=Rsteam·Crs (5)
For resistance to air flow and respiratory compliance, the following equations yield:
In healthy adult subjects, typical values for resistance and compliance are Rair=2 . . . 4 mbar s/l and Crs=230 . . . 290 ml/mbar. However, both parameters vary strongly with lung volume and are thus functions of the operating point.
In ventilated subjects, the pressures are somewhat different. Due to a muscle relaxation, the subathmospheric pressure created by the diaphragm is often set to 0. From the ventilator, a positive airway pressure is applied to the respiratory system. The endotracheal tube often causes turbulent flow and an additional resistance to air flow (Rtube) which may be considered by an additional quadratic term
Palv=Palv.O
Note that the steam partial pressure palv.H
Palv.O
Thus, during normal pressure ventilation the arterial partial pressure of oxygen may never exceed 674 mm Hg.
From the alveoles to the blood, oxygen is transported by passive diffusion which can be described by Fick's law
The gas flow is directly proportional to the area of gas exchange (Adiff) and in inverse proportion to the diffusion length ldiff. In healthy subjects, the gas exchange occurs rather fast (<<1 s). Note that the diffusion coefficient for CO2 is approx. 20× larger than the coefficient for O2.
The mechanical large-scale characterics are best described by a pV curve.
Note that a healthy lung has a significant compliance (Crs>0) over the whole operating range and may be ventilated with a sufficient tidal volume at typical airway pressures (like e.g. PIP=20 mbar, PEEP=5 mbar).
However, an ailing lung shows a different hysteresis. Especially on the ascending branch, a low tidal volume may occur. In this section of the large-scale characteristic of the lung, a major fraction of alveoles is collapsed and may not participate in gas exchange.
This fact is even more illucidated when watching the large-scale characteristic of paO2.
For such an ailing lung, an optimal ventilation strategy could be to first open the lung with a temporary high airway pressure and then ventilate on the descending branch of the hysteresis such that a sufficient tidal volume is reached and gas exchange is maintained.
The mechanical hysteresis found in healthy lungs (
For an optimized ventilatory therapy adapted to the individual patient, it is very important to know the static and dynamic properties of his lung. Since the condition of the lung may change significantly within a short period of time, it is important the identify the lung condition as frequent as necessary.
At low air flows, the resistive influence of the endotracheal tube may be linearized and included into Rair.
Resistance to air flow and respiratory compliance may be computed from the expiratory flow curve. Assuming Rair and Crs to be constant during expiration, the following eq. yields
As a matter of fact, the expiratory time constant {circumflex over (T)}rs may be computed from a least squares fit of the measured expiratory flow curve. Note that both small-scale characteristic parameters change with specific diseases (e.g. Rair increases during obstructive diseases), but are also functions of lung volume. Thus, knowing the small-scale characteristics of a specific lung alone may no be sufficient to evaluate the status of a patient. For an optimized ventilation, it is important to know the large-scale status of the lung as well.
For identification of the large-scale characteristics of a lung, a pressure ramp may be used which allows to completely cover the hysteresis. As an example,
Note that obtaining the alveolar opening and closing pressures from monitoring paO2 during airway pressure changes is already known from the publication Leonhardt, S., Böhm, S and Lachmann B., “Optimierung der Beatmung beim akuten Lungenversagen durch Identifikation physiologischer Kenngröβen”, Automatisierungstechnik (at), Vol. 46, No. 11, pp 532-539, 1998, as mentioned above. With the methods claimed in this invention, the same information may be obtained by using noninvasive measurements instead of the invasive paO2.
To determine alveolar opening and closing pressures, a generally known and accepted definition can be applied. This definition states that a lung is “surely open” if paO2>450 mmHg when the inspiratory oxygen fraction applied to the patient is fiO2=100%. Under the same conditions, a lung is said to be “surely closed” (predominantly collapsed) if paO2<300 mmHg. Note that the paO2 hysteresis as shown in
A known strategy for protective long-term ventilation is to first identify the opening and closing pressures, to afterwards reopen the lung with airway pressures above the opening pressure and then to ventilate with airway pressures shortly above the identified closing pressure.
As shown in
In
PEEP=PEEPclose+2 mmHg (15)
and PIP such that the corresponding tidal volume lies within acceptable limits. However, any PIP settings above the corresponding closing pressure are also possible.
Instead of the paO2 signal obtained invasively, the method claimed in this invention utilizes the endtidal CO2 concentration and/or the CO2 output as feedback signals for identification of the optimal ventilator settings for ailing lungs. Both feedback signals can be measured noninvasively. In a preferred implementation of the invention, a closed loop system as given in
The automatic tuning of the ventilator settings may be realized by using an external apparatus (e.g. an additional personal computer) or by integration into the internal ventilator software.
Note that the CO2 output (in [ml CO2/min]) from the body can be obtained from continuous measurements of the CO2 concentration [in %] and air flow (in [ml/min]) and subsequent breathwise computation of
during expiration. Balancing CO2 production and elimination in the body gives the CO2 content stored in the body
In a paralyzed patient, CO2 production may assumed to be constant, at least within a time frame of some minutes to a few hours. Within this period, additional physiological control mechanisms like the pH control loop via the kidneys can be neglected due to their slow long-term orientation. Typical values for CO2 production are around 5 . . . 7 ml/kg min.
If the CO2 output from the body is reduced due to a partial lung collapse, the like CO2 content stored in the body fluids and also the arterial paCO2=′f(VCO
It is known that in healthy lungs with a small fraction of atelectatic alveoles and a small mechanical hysteresis, the CO2 output may be raised by increasing PIP-PEEP (and thus the tidal volume). Of course, in this case paCO2 will drop (remember that paCO2 may also be influenced by changing I/E or RR). In ailing lungs featuring a larger hysteresis, this fact may be employed for identification of the hysteresis characteristics (i.e. alveolar opening and closing pressures).
Before starting an identification procedure based on CO2 output, it is important to obtain a “steady state” at a higher CO2 level. This can be done by choosing a somewhat low RR. If the ventilation pressures are now increased, an alveolar opening can be detected from a sudden increase and possibly an overshoot in etCO2 and CO2 output. As a consequence of the increased CO2 elimination from the body, VCO
If the ventilation pressures are afterwards decreased again, an alveolar collapse can be detected from a significant decrease in etCO2 and/or CO2 output.
As an alternative to the method described above, it is also possible to identify alveolar opening and closing by monitoring the relative changes of the etCO2 and/or the CO2 output signal.
After identification of alveolar opening and closing pressures, the lung may be openend again by applying pressures above opening pressure and subsequently be ventilated by setting the PEEP above closing pressure. Since the etCO2 is proportional to paCO2 in an open lung, paCO2 may afterwards be feedback controlled and kept within physiological limits.
Instead of the paO2 signal obtained invasively, in another preferred embodiment of this invention the hemoglobin oxygen saturation (SO2) measured nonivasively is used as a feedback signal for identification of optimal ventilation parameters for ailing lungs.
To apply the method claimed in this invention, it is assumed that the SO2 is valid, i.e. peripheral measurements of hemoglobin oxygen saturation are accessable (the patient is not in shock or centralizing due to other reasons, etc.).
As has been explained already, in the preferred embodiment of the invention SO2 is not used as a feedback signal directly, but is controlled within a cascaded feedback control loop to stay within given limits. Thus, the inspiratory oxygen fraction (fiO2) required to keep SO2 constant serves as an indirect signal to identify the lung hysteresis
By preference, the performance of the SO2 controller is so high that SO2 stays constant even if other ventilation parameters are changed. Under these circumstances, fiO2 serves as an indicator for the fraction of collapsed alveoles. For example, if a high fiO2 is required (e.g. fiO2≧70%) to reach SO2=90%, the lung is mainly collapsed. By contrast, if a low fiO2 (e.g. 30%) is sufficient to reach SO2=90%, the lung is mainly open.
This fact may be used to identify the large-scale gas exchange hysteresis of ailing lungs as introduced above. In a preferred embodiment of the invention, the ventilation pressures are modified while SO2 control is active.
Note that at lower fiO2 levels, the resistance to diffusion is relatively increased. Also, it must be kept in mind that if a lung has been opened and is now ventilated at low pressures and low fiO2 levels, a subsequent collapse is potentially hazardous to the patient. The reason for this danger is that during a collapse, the lung volume decreases very fast. Thus, the now dramatically reduced gas exchange area may not be large enough any more for transfer of sufficient oxygen. In order to avoid an insufficient oxygen supply and possible damage to the patient, the SO2 control is required to react fast.
After successfull identification of the opening and closing pressures and subsequent reopening of the lung, a protective long-term ventilation above the closing pressures as already explained in
Leonhardt, Steffen, Böhm, Stephan
Patent | Priority | Assignee | Title |
10046134, | Mar 24 2015 | VENTEC LIFE SYSTEMS, INC | Pressure swing adsorption oxygen generator |
10105509, | Mar 24 2015 | VENTEC LIFE SYSTEMS, INC | Active exhalation valve |
10245406, | Mar 24 2015 | VENTEC LIFE SYSTEMS, INC | Ventilator with integrated oxygen production |
10315002, | Mar 24 2015 | VENTEC LIFE SYSTEMS, INC | Ventilator with integrated oxygen production |
10518059, | Mar 24 2015 | VENTEC LIFE SYSTEMS, INC | Passive leak valve |
10543326, | Nov 08 2012 | Covidien LP | Systems and methods for monitoring, managing, and preventing fatigue during ventilation |
10576237, | Mar 24 2015 | TENSORX, INC | Active exhalation valve |
10639441, | Mar 11 2013 | Covidien LP | Methods and systems for managing a patient move |
10668239, | Nov 14 2017 | Covidien LP | Systems and methods for drive pressure spontaneous ventilation |
10758699, | Mar 24 2015 | VENTEC LIFE SYSTEMS, INC | Secretion trap |
10773049, | Jun 21 2016 | Ventec Life Systems, Inc. | Cough-assist systems with humidifier bypass |
10806879, | Apr 27 2012 | Covidien LP | Methods and systems for an optimized proportional assist ventilation |
10905836, | Apr 02 2015 | HILL-ROM SERVICES PTE LTD | Manifold for respiratory device |
10905837, | Apr 02 2015 | HILL-ROM SERVICES PTE. LTD. | Respiratory therapy cycle control and feedback |
11185655, | Mar 24 2015 | Ventec Life Systems, Inc. | Passive leak valve |
11191915, | May 13 2018 | VENTEC LIFE SYSTEMS, INC | Portable medical ventilator system using portable oxygen concentrators |
11229759, | Nov 08 2012 | Covidien LP | Systems and methods for monitoring, managing, and preventing fatigue during ventilation |
11247015, | Mar 24 2015 | Ventec Life Systems, Inc. | Ventilator with integrated oxygen production |
11291791, | Mar 24 2015 | Ventee Life Systems, Inc. | Ventilator with integrated cough-assist |
11344692, | Mar 24 2015 | Ventec Life Systems, Inc. | Respiratory therapy systems and methods |
11517691, | Sep 07 2018 | Covidien LP | Methods and systems for high pressure controlled ventilation |
11559643, | Nov 14 2017 | Covidien LP | Systems and methods for ventilation of patients |
11679229, | Jun 21 2016 | Ventec Life Systems, Inc. | Cough-assist systems with humidifier bypass |
8251876, | Apr 22 2008 | HILL-ROM SERVICES PTE LTD | Breathing exercise apparatus |
8528553, | Nov 16 2006 | HAMILTON MEDICAL AG | Method and device for determining the PEEP during the respiration of a patient |
8776792, | Apr 29 2011 | Covidien LP | Methods and systems for volume-targeted minimum pressure-control ventilation |
9180271, | Mar 05 2012 | HILL-ROM SERVICES PTE. LTD.; HILL-ROM SERVICES PTE LTD | Respiratory therapy device having standard and oscillatory PEP with nebulizer |
9358355, | Mar 11 2013 | Covidien LP | Methods and systems for managing a patient move |
9375542, | Nov 08 2012 | Covidien LP | Systems and methods for monitoring, managing, and/or preventing fatigue during ventilation |
9956371, | Mar 24 2015 | Ventec Life Systems, Inc.; VENTEC LIFE SYSTEMS, INC | Ventilator with integrated cough-assist |
9993604, | Apr 27 2012 | Covidien LP | Methods and systems for an optimized proportional assist ventilation |
Patent | Priority | Assignee | Title |
5103814, | Apr 28 1988 | Self-compensating patient respirator | |
5388575, | Sep 25 1992 | Adaptive controller for automatic ventilators | |
5660170, | Jun 02 1995 | Burkhard, Lachmann | Respiratory apparatus and method for determining an optimal opening pressure in a lung system |
5738090, | Jun 02 1995 | Burkhard, Lachmann | Respiratory system for determining an opening pressure of a long system and maintaining the lung system open |
5752509, | Jul 10 1995 | LACHMANN, BURKHARD | Artificial ventilation system |
5937854, | Jan 06 1998 | SensorMedics Corporation | Ventilator pressure optimization method and apparatus |
6116241, | Jul 08 1996 | Maquet Critical Care AB | Method and apparatus for determining when a partially or completely collapsed lung has been opened |
EP728493, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 25 2006 | Maquet Critical Care AB | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Feb 10 2011 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Jan 11 2013 | ASPN: Payor Number Assigned. |
Feb 26 2015 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Jun 24 2011 | 4 years fee payment window open |
Dec 24 2011 | 6 months grace period start (w surcharge) |
Jun 24 2012 | patent expiry (for year 4) |
Jun 24 2014 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jun 24 2015 | 8 years fee payment window open |
Dec 24 2015 | 6 months grace period start (w surcharge) |
Jun 24 2016 | patent expiry (for year 8) |
Jun 24 2018 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jun 24 2019 | 12 years fee payment window open |
Dec 24 2019 | 6 months grace period start (w surcharge) |
Jun 24 2020 | patent expiry (for year 12) |
Jun 24 2022 | 2 years to revive unintentionally abandoned end. (for year 12) |